Form 4: HealthStream EVP O'Hara Reports RSU Vesting & Tax Withholding
Insider Transaction Report
HealthStream's Executive Vice President, Kevin P. O'Hara, reported the vesting of restricted share units and subsequent share withholding for tax liabilities.
Summary
- Kevin P. O'Hara, Executive Vice President of HealthStream Inc. (HSTM), reported changes in his beneficial ownership.
- He acquired 4,718 shares of common stock on February 27, 2026, due to the vesting of restricted share units (RSUs).
- Concurrently, 1,399 shares were disposed of on February 27, 2026, at a price of $22.09 per share, to cover tax liabilities associated with the RSU vesting.
- Following these transactions, O'Hara directly beneficially owns 19,692 shares of common stock.
- Several tranches of Restricted Share Units (RSUs) vested, totaling 4,718 units (2,000 + 915 + 1,803), as performance criteria for the period January 1, 2025, through December 31, 2025, were achieved.
- Remaining derivative securities (RSUs) beneficially owned are 4,500, 4,575, and 10,220 units from different awards.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive indicator, reflecting the achievement of performance targets for executive compensation and routine insider activity, which suggests operational stability and management alignment with shareholder interests.
Positives
- Performance criteria for the period January 1, 2025, through December 31, 2025, were achieved, leading to the vesting of restricted share units.
- The vesting of RSUs indicates continued service and successful performance by the Executive Vice President.
Negatives
- 1,399 shares were disposed of to cover tax liabilities, reducing the direct beneficial ownership of common stock.
Future Outlook
Future vesting of restricted share units is contingent upon continued service and the achievement of annually established performance criteria by the Compensation Committee, with vesting schedules extending through February 2030.
Industry Context
StockSavvy.ai notes that RSU vesting and subsequent tax-related sales are standard practices in executive compensation across the healthcare technology sector, reflecting performance-based incentives and routine insider transaction disclosures.
Stakeholder Impact
- Shareholders: The vesting of RSUs and subsequent tax-related sales are routine and reflect the company's executive compensation structure. The achievement of performance criteria for vesting could be seen positively as it aligns executive incentives with company performance.
- Employees: The RSU program demonstrates a performance-based compensation structure for executives, which may influence broader employee incentive programs.
Next Steps
- Future tranches of restricted share units are scheduled to vest on various dates through February 2030, contingent on continued service and achievement of performance criteria.
- The Compensation Committee of the Board of Directors will establish performance criteria annually for future RSU vesting.
Key Dates
| Date | Description |
|---|---|
| 2023-01-01 | Start of performance period for certain Restricted Share Units (RSUs). |
| 2023-12-31 | End of performance period for certain RSUs. |
| 2024-01-01 | Start of performance period for certain RSUs. |
| 2024-02-23 | Vesting date for 15% of certain RSUs related to the January 1, 2023 December 31, 2023 performance period. |
| 2024-06-30 | End of performance period for certain RSUs. |
| 2024-07-01 | Start of performance period for certain RSUs. |
| 2024-12-31 | End of performance period for certain RSUs. |
| 2025-01-01 | Start of performance period for multiple tranches of RSUs. |
| 2025-02-23 | Vesting date for 20% of certain RSUs related to the January 1, 2024 December 31, 2024 performance period, and 10% of other RSUs related to the July 1, 2024 December 31, 2024 performance period. |
| 2025-12-31 | End of performance period for multiple tranches of RSUs, for which performance criteria were achieved. |
| 2026-01-01 | Start of performance period for multiple tranches of RSUs. |
| 2026-02-23 | Vesting date for 20% of certain RSUs related to the January 1, 2025 December 31, 2025 performance period, and 15% of other RSUs related to the January 1, 2025 December 31, 2025 performance period. |
| 2026-02-27 | Transaction date for RSU vesting and share disposition for tax, and signature date. Also, vesting date for 15% of certain RSUs related to the January 1, 2025 December 31, 2025 performance period. |
| 2026-12-31 | End of performance period for multiple tranches of RSUs. |
| 2027-01-01 | Start of performance period for multiple tranches of RSUs. |
| 2027-02-23 | Vesting date for 20% of certain RSUs related to the January 1, 2026 December 31, 2026 performance period, and 20% of other RSUs related to the January 1, 2026 December 31, 2026 performance period. |
| 2027-02-27 | Vesting date for 20% of certain RSUs related to the January 1, 2026 December 31, 2026 performance period. |
| 2027-12-31 | End of performance period for multiple tranches of RSUs. |
| 2028-01-01 | Start of performance period for multiple tranches of RSUs. |
| 2028-02-23 | Vesting date for 25% of certain RSUs related to the January 1, 2027 December 31, 2027 performance period, and 25% of other RSUs related to the January 1, 2027 December 31, 2027 performance period. |
| 2028-02-27 | Vesting date for 20% of certain RSUs related to the January 1, 2027 December 31, 2027 performance period. |
| 2028-12-31 | End of performance period for multiple tranches of RSUs. |
| 2029-01-01 | Start of performance period for multiple tranches of RSUs. |
| 2029-02-23 | Vesting date for 30% of certain RSUs related to the January 1, 2028 December 31, 2028 performance period. |
| 2029-02-27 | Vesting date for 20% of certain RSUs related to the January 1, 2028 December 31, 2028 performance period. |
| 2029-12-31 | End of performance period for certain RSUs. |
| 2030-01-01 | Start of performance period for certain RSUs. |
| 2030-02-27 | Vesting date for 25% of certain RSUs related to the January 1, 2029 December 31, 2029 performance period. |
| 2030-12-31 | End of performance period for certain RSUs. |
Recommendation
holdThis Form 4 filing details routine insider transactions related to executive compensation, specifically the vesting of restricted share units and subsequent share sales for tax purposes. It does not contain new material information regarding the company's financial performance, strategic direction, or significant operational changes that would warrant a change in investment recommendation. The achievement of performance criteria for RSU vesting is a positive signal regarding executive performance but is already factored into ongoing operations. Therefore, a "hold" recommendation is appropriate as this filing alone does not present a compelling reason to buy or sell.
Keywords
HealthStream, HSTM, Kevin O'Hara, Form 4, Insider Trading, Restricted Share Units, RSU Vesting, Executive Compensation, Stock Ownership, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.